ArticleDiabetes & metabolic syndrome

Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).

Kunal Mahajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.